Patents by Inventor Amber Nasreen

Amber Nasreen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Muteins of tear lipocalin with affinity for the T-cell coreceptor CD4
    Patent number: 8598317
    Abstract: The present invention relates to a mutein of human tear lipocalin, wherein the mutein comprises at least one mutated amino acid residue at any two or more of the sequence positions 24-36, 53-66, 79-84, and 102-110 (or 103-110) of the linear polypeptide sequence of the mature human tear lipocalin, and wherein the mutein binds to the extracellular region of the T-cell coreceptor CD4 with detectable affinity. The invention also relates to a method of generating such a mutein as well as to various pharmaceutical uses of such a mutein.
    Type: Grant
    Filed: March 20, 2007
    Date of Patent: December 3, 2013
    Assignee: Technische Universitaet Muenchen
    Inventors: Arne Skerra, Amber Nasreen
  • MUTEINS OF TEAR LIPOCALIN WITH AFFINITY FOR THE T-CELL CORECEPTOR CD4
    Publication number: 20100160612
    Abstract: The present invention relates to a mutein of human tear lipocalin, wherein the mutein comprises at least one mutated amino acid residue at any two or more of the sequence positions 24-36, 53- 66, 79-84, and 102-110 (or 103-110) of the linear polypeptide sequence of the mature human tear lipocalin, and wherein the mutein binds to the extracellular region of the T-cell coreceptor CD4 with detectable affinity. The invention also relates to a method of generating such a mutein as well as to various pharmaceutical uses of such a mutein.
    Type: Application
    Filed: March 20, 2007
    Publication date: June 24, 2010
    Inventors: Arne Skerra, Amber Nasreen